Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Establishing risk of human experimentation with drugs: lessons from TGN1412.

× No keyword cloud information.

43 in total

Review 1. Developing drug prototypes: pharmacology replaces safety and tolerability?

Authors: Adam F Cohen
Journal: Nat Rev Drug Discov Date: 2010-09-17 Impact factor: 84.694

2. More on first-in-man studies.

Authors: J M Ritter
Journal: Br J Clin Pharmacol Date: 2010-11 Impact factor: 4.335

3. From pharmacology to immunopharmacology.

Authors: Adam Cohen
Journal: Br J Clin Pharmacol Date: 2006-10 Impact factor: 4.335

4. The precautionary principle should not be used as a basis for decision-making. Talking point on the precautionary principle.

Authors: Martin Peterson
Journal: EMBO Rep Date: 2007-04 Impact factor: 8.807

Review 5. Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412.

Authors: C M Dayan; D C Wraith
Journal: Clin Exp Immunol Date: 2008-02 Impact factor: 4.330

6. Should we tolerate tolerability as an objective in early drug development?

Authors: A Cohen
Journal: Br J Clin Pharmacol Date: 2007-09 Impact factor: 4.335

7. Why animal studies are often poor predictors of human reactions to exposure.

Authors: Michael B Bracken
Journal: J R Soc Med Date: 2009-03 Impact factor: 5.344

Review 8. Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology.

Authors: Austin Wt Chiang; Shangzhong Li; Philipp N Spahn; Anne Richelle; Chih-Chung Kuo; Mojtaba Samoudi; Nathan E Lewis
Journal: Curr Opin Struct Biol Date: 2016-09-14 Impact factor: 6.809

9. Medical progress depends on animal models--doesn't it?

Authors: Susan Green
Journal: J R Soc Med Date: 2008-05 Impact factor: 5.344

Review 10. Imaging in targeted delivery of therapy to cancer.

Authors: Gairin Dancey; Richard H Begent; Tim Meyer
Journal: Target Oncol Date: 2009-10-08 Impact factor: 4.493